MJBizDaily
Federal marijuana rescheduling means institutional capital is coming to cannabis investing
Latest Posts
SEC sues cannabis investment fund, warns investors about MJ industry ‘scam artists’
The U.S. Securities and Exchange Commission charged a marijuana-focused investment fund with bilking investors out of more than $3 million and simultaneously warned the public about “scam artists” exploiting “hot” industries such…
News September 6Ontario signs up first marijuana accessories suppliers
The Ontario Cannabis Store - the province's government-operated wholesaler and online retailer - inked deals with 10 accessories suppliers to provide products to offer alongside recreational marijuana when sales begin…
News September 6New Jersey flooded with applications for six medical marijuana licenses
New Jersey received 146 applications for six new medical marijuana licenses, an expansion that will double the number of MMJ businesses in a rapidly growing market. Applicants had to identify the…
News September 6Judge: Oregon county’s lawsuit against state cannabis law should be dismissed
A federal lawsuit filed by a southern Oregon county with a large number of cannabis growers looks likely to fail after a magistrate judge recommended the case be tossed out.…
News September 6Number of cannabis racketeering suits increases, posing financial threat to targeted firms
Federal civil racketeering lawsuits are proliferating against marijuana businesses, forcing companies to sometimes spend tens of thousands of dollars to cover legal costs. Experts are divided about the risk the…
News September 6Marlboro maker ‘evaluating opportunities’ in cannabis industry
Altria Group, one of the largest tobacco companies in North America, is assessing its market opportunities in the cannabis industry. The entry of Altria – owner of Marlboro maker Philip…
News September 5Mississippi group starts drive to get medical marijuana on 2020 ballot
A group in Mississippi, one of the country’s most conservative states, is aiming to put what looks to be a business-friendly medical marijuana initiative on the ballot in 2020.
News September 5Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids
Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer a wide range of cannabinoids found in cannabis.
News September 5Oregon marijuana firm lands $12.5M from Canada’s Tidal Royalty to fund expansion
Oregon-based Diem Cannabis is poised to enter a new market after landing upwards of $12.5 million in financing from Toronto-based Tidal Royalty Corp. The capital will be used over the…
News September 5












